Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

PURPOSE OF REVIEW: The aim of this review is to summarize the available clinical efficacy and safety data related to the most studied and used lipid-lowering nutraceuticals. RECENT FINDINGS: A growing number of meta-analyses of randomized clinical trials supports the effectiveness and tolerability o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicero, Arrigo F. G., Fogacci, Federica, Stoian, Anca Pantea, Vrablik, Michal, Al Rasadi, Khalid, Banach, Maciej, Toth, Peter P., Rizzo, Manfredi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Nonstatin Drugs (M. Vrablik, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332568/
https://www.ncbi.nlm.nih.gov/pubmed/34345932
http://dx.doi.org/10.1007/s11883-021-00955-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332568/
https://www.ncbi.nlm.nih.gov/pubmed/34345932
http://dx.doi.org/10.1007/s11883-021-00955-y

Ejemplares similares